Vabysmo 6 MG per 0.05 ML Prefilled Syringe
- RxCUI
- 2692688
- RxNorm name
- Vabysmo 6 MG per 0.05 ML Prefilled Syringe
- Display name
- Vabysmo 6 MG per 0.05 ML Prefilled Syringe
- Full name
- Vabysmo 6 MG per 0.05 ML Prefilled Syringe
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761235 | Vabysmo | faricimab-svoa | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VABYSMO | FARICIMAB | Genentech, Inc. | 04cc9ef7-c02a-4e92-a655-0062674e8487 | 2026-04-15 | Warnings, Adverse reactions | 2692688 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 04cc9ef7-c02a-4e92-a655-0062674e8487 | Vabysmo 6 MG per 0.05 ML Prefilled Syringe | SY | 11 | These highlights do not include all the information needed to use VABYSMO safely and effectively. See full prescribing information for VABYSMO. VABYSMO ® (faricimab-svoa) injection, for intravitreal use Initial U.S. Approval: 2022 | 20260415 |
| 04cc9ef7-c02a-4e92-a655-0062674e8487 | Vabysmo 6 MG in 0.05 ML Prefilled Syringe | PSN | 11 | These highlights do not include all the information needed to use VABYSMO safely and effectively. See full prescribing information for VABYSMO. VABYSMO ® (faricimab-svoa) injection, for intravitreal use Initial U.S. Approval: 2022 | 20260415 |
| 04cc9ef7-c02a-4e92-a655-0062674e8487 | 0.05 ML Vabysmo 120 MG/ML Prefilled Syringe | SY | 11 | These highlights do not include all the information needed to use VABYSMO safely and effectively. See full prescribing information for VABYSMO. VABYSMO ® (faricimab-svoa) injection, for intravitreal use Initial U.S. Approval: 2022 | 20260415 |
| 04cc9ef7-c02a-4e92-a655-0062674e8487 | 0.05 ML faricimab-svoa 120 MG/ML Prefilled Syringe [Vabysmo] | SBD | 11 | These highlights do not include all the information needed to use VABYSMO safely and effectively. See full prescribing information for VABYSMO. VABYSMO ® (faricimab-svoa) injection, for intravitreal use Initial U.S. Approval: 2022 | 20260415 |